Ahmed Idbaih
Overview
Explore the profile of Ahmed Idbaih including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
10376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicario R, Fragkogianni S, Pokrovskii M, Meyer C, Lopez-Rodrigo E, Hu Y, et al.
Neuron
. 2025 Mar;
PMID: 40081365
Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are clonal myeloid disorders associated with mitogen-activated protein (MAP)-kinase-activating mutations and an increased risk of neurodegeneration. We found microglial mutant clones in...
2.
Deboeuf L, Riche M, Malaize H, Marijon P, Mokhtari K, Bielle F, et al.
J Neurosurg
. 2025 Feb;
:1-10.
PMID: 40020233
Objective: There is a lack of data regarding the benefit-risk ratio and therapeutic value of brain biopsy in very elderly patients with brain tumors. This study aimed to evaluate the...
3.
Talpin A, Maia A, Carpier J, Kulakowski G, Aubergeon L, Kervevan J, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39979071
Background: Molecular mimicry between commensal bacterial antigens and tumor-associated antigens (TAAs) has shown potential in enhancing antitumor immune responses. This study leveraged this concept using commensal bacterial antigens, termed OncoMimics,...
4.
Razanamahery J, Idbaih A, Papo M, Robelin F, Emile J, Audia S, et al.
Haematologica
. 2025 Jan;
PMID: 39815815
Not available.
5.
Villar-Quiles R, Bouaoud J, Foy J, Behin A, Masingue M, Nguyen T, et al.
Clin Teach
. 2025 Jan;
22(1):e70024.
PMID: 39789819
Background: The acquisition of practical skills is a key objective of medical education. Improving knowledge and skills is essential for early diagnosis of patients suffering from neuromuscular (NM) diseases. Approach:...
6.
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, et al.
Cancer Treat Rev
. 2024 Dec;
132:102866.
PMID: 39709267
No abstract available.
7.
Khuu A, Verreault M, Colin P, Tran H, Idbaih A
Cells
. 2024 Nov;
13(22).
PMID: 39594617
Antisense oligonucleotides (ASOs) are promising drugs capable of modulating the protein expression of virtually any target with high specificity and high affinity through complementary base pairing. However, this requires a...
8.
Cella E, Bosio A, Persico P, Caccese M, Padovan M, Losurdo A, et al.
Cancer Treat Rev
. 2024 Nov;
131:102850.
PMID: 39531943
Gliomas are the most common primary malignant brain tumours in adults. Despite decades of research into novel therapeutic approaches, the prognosis remains poor. PARP1-2 are critical for DNA repair, cell...
9.
Figarella-Branger D, Colin C, Mokhtari K, Uro-Coste E, Idbaih A, Appay R, et al.
Neuro Oncol
. 2024 Oct;
27(3):755-766.
PMID: 39432559
Background: In the POLA cohort, 3 pathological groups of CNS WHO grade 3 oligodendroglioma IDH-mutant and 1p/19q co-deleted have been described: group 1 (high mitotic count only), group 2 (microvascular...
10.
van den Bent M, Franceschi E, Touat M, French P, Idbaih A, Lombardi G, et al.
Neuro Oncol
. 2024 Oct;
27(2):331-337.
PMID: 39387386
The standard of care for adult patients with gliomas, glioneuronal, and neuronal tumors consists of combinations of surgery, radiotherapy, and chemotherapy. For many systemic cancers, targeted treatments are a major...